United States· US:0378-0221_30d62085-4192-46af-b05a-da3eed7d1fc5
Timolol Maleate
A timolol product containing timolol maleate, registered in United States by Mylan Pharmaceuticals Inc.. The same ATC class is registered in 8 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Timolol is registered in 8 of 19 countries.
Countries holding a registration under ATC C07AA06 (timolol), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Timolol · ATC C07AA06
8 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Ireland
- Japan
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TIMOLOL MALEATE
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- C07AA06
- ATC class
- Timolol
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc110378022101100 TABLET in 1 BOTTLE, PLASTIC (0378-0221-01)
- ndc110378-0221-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
310 interactions on record for timolol.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Timolol · interactions on record
310 records
- 31 severe
- 189 moderate
- 23 minor
- 67 info
Most severe, free to view
- DolasetronA04AA04severe
- EpinephrineB02BC09severe
- EpinephrineC01CA24severe
- OrciprenalinC01CA29severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Timolol in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBetim 10mg tabletsLexon (UK) Ltd
- NorwayBlocadrenLaboratorio Farmaceutico S.I.T. Srl
- CanadaTIMOLOLAA PHARMA INC
- FinlandBlocanolMerck Sharp & Dohme B.V.
- FranceTIMACOR 10 mg, comprimé sécableETHYX PHARMACEUTICALS
- BelgiumAkistancomb 50 µg/ml - 5 mg/mlPharmaselect International Beteiligungs
- ItalyBLOCADREN*40 cpr 10 mgSIT LABORATORIO FARMAC. Srl
- GermanyArutimol®Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Timoftal, Timolol Micro Labs
- Belgium · Geltim, Timabak
- Bulgaria · Гелтим, Кузимолол
- Cyprus · Lithimole
- Czechia · Oftan, Timo-Comod
- Germany · Dispatim, Gelisia
- Denmark · Eyopto, Optimol
- Estonia · Timosan
- Spain · Cusimolol, Gelisia
- Finland · Oftan Timolol, Timosan
- France · Geltim Lp, Genoptol
- United Kingdom (Northern Ireland) · Eysano, Timolol Blumont Pharma
- Greece · Geltim, Lithimole
- Croatia · Timalen
- Hungary · Cusimolol
- Ireland · Timofluid, Timolol Brown & Burk Ir
- Iceland · Timosan Depot
- Italy · Blocadren, Cusimolol
- Lithuania · Oftan, Timosan
- Luxembourg · Dispatim, Geltim
- Latvia · Oftan Timolol, Timosan
- Malta · Lithimole
- Netherlands · Gelisia, Timo-Comod
- Norway · Oftan, Timosan
- Poland · Cusimolol, Timo-Comod 0,5 %
- Portugal · Dibetop, Timabak
- Romania · Gelisia, Geltim
- Sweden · Optimol, Timosan
- Slovenia · Timalen, Timoptic -Xe
- Slovakia · Unitimolol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ebe91bb4-8778-46e9-b4bd-2159692de2bf GET /v1/drugs/ebe91bb4-8778-46e9-b4bd-2159692de2bf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "10",
"substance": "TIMOLOL MALEATE",
"productndc": "0378-0221",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA072668",
"marketing_category": "ANDA"
}See everything about timolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.